Last updated: 27 November 2023 at 4:43pm EST

Dr. Cameron Turtle DPHIL, Ph.D. Net Worth




The estimated Net Worth of Cameron Turtle is at least $6.4 Milión dollars as of 28 December 2020. Dr Turtle owns over 19,500 units of BridgeBio Pharma Inc stock worth over $897,583 and over the last 5 years he sold BBIO stock worth over $4,883,581. In addition, he makes $621,400 as Chief Strategy Officer at BridgeBio Pharma Inc.

Dr D BBIO stock SEC Form 4 insiders trading

Dr has made over 24 trades of the BridgeBio Pharma Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 19,500 units of BBIO stock worth $130,455 on 28 December 2020.

The largest trade he's ever made was exercising 26,294 units of BridgeBio Pharma Inc stock on 15 December 2020 worth over $363,909. On average, Dr trades about 6,934 units every 19 days since 2019. As of 28 December 2020 he still owns at least 32,068 units of BridgeBio Pharma Inc stock.

You can see the complete history of Dr Turtle stock trades at the bottom of the page.





Dr. Cameron Turtle DPHIL, Ph.D. biography

Dr. Cameron Turtle DPHIL, Ph.D. is the Chief Strategy Officer at BridgeBio Pharma Inc.

What is the salary of Dr D?

As the Chief Strategy Officer of BridgeBio Pharma Inc, the total compensation of Dr D at BridgeBio Pharma Inc is $621,400. There are 14 executives at BridgeBio Pharma Inc getting paid more, with Neil Kumar having the highest compensation of $26,334,100.



How old is Dr D?

Dr D is 31, he's been the Chief Strategy Officer of BridgeBio Pharma Inc since . There are 19 older and 2 younger executives at BridgeBio Pharma Inc. The oldest executive at BridgeBio Pharma Inc is Dr. Charles J. Homcy M.D., 73, who is the Chairman of Pharmaceuticals & Lead Director.

What's Dr D's mailing address?

Cameron's mailing address filed with the SEC is 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453.

Insiders trading at BridgeBio Pharma Inc

Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo a Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.



What does BridgeBio Pharma Inc do?

we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.



What does BridgeBio Pharma Inc's logo look like?

BridgeBio Pharma Inc logo

Complete history of Dr Turtle stock trades at Aeglea BioTherapeutics Inc, Eidos Therapeutics Inc a BridgeBio Pharma Inc

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
28 Dec 2020 Cameron Turtle
See Remarks
Využitie opcie 19,500 $6.69 $130,455
28 Dec 2020
32,068
24 Nov 2020 Cameron Turtle
See Remarks
Využitie opcie 5,000 $17.00 $85,000
24 Nov 2020
13,310
5 Nov 2020 Cameron Turtle
See Remarks
Využitie opcie 2,500 $17.00 $42,500
5 Nov 2020
15,068
30 Sep 2020 Cameron Turtle
See Remarks
Využitie opcie 14,500 $3.14 $45,530
30 Sep 2020
27,068
18 Sep 2020 Cameron Turtle
See Remarks
Využitie opcie 2,500 $17.00 $42,500
18 Sep 2020
15,068
15 Sep 2020 Cameron Turtle
See Remarks
Využitie opcie 2,500 $17.00 $42,500
15 Sep 2020
15,068
11 Sep 2020 Cameron Turtle
See Remarks
Využitie opcie 2,000 $0.34 $680
11 Sep 2020
14,568
30 Jun 2020 Cameron Turtle
See Remarks
Využitie opcie 10,000 $0.23 $2,300
30 Jun 2020
19,823
27 Apr 2020 Cameron Turtle
See Remarks
Využitie opcie 2,000 $17.00 $34,000
27 Apr 2020
11,823
8 Apr 2020 Cameron Turtle
See Remarks
Využitie opcie 8,000 $17.00 $136,000
8 Apr 2020
17,823
11 Feb 2020 Cameron Turtle
See Remarks
Využitie opcie 2,000 $17.00 $34,000
11 Feb 2020
11,823
8 Jan 2020 Cameron Turtle
See Remarks
Predaj 12,807 $34.37 $440,177
8 Jan 2020
9,823
15 Dec 2020 Cameron Turtle
Chief Business Officer
Využitie opcie 26,294 $13.84 $363,909
15 Dec 2020
76,915
11 Nov 2020 Cameron Turtle
Chief Business Officer
Predaj 13,410 $74.51 $999,179
11 Nov 2020
52,121
2 Nov 2020 Cameron Turtle
Chief Business Officer
Predaj 12,500 $70.72 $884,000
2 Nov 2020
65,531
10 Sep 2020 Cameron Turtle
Chief Business Officer
Využitie opcie 2,500 $17.00 $42,500
10 Sep 2020
73,031
3 Aug 2020 Cameron Turtle
Chief Business Officer
Predaj 10,000 $39.94 $399,400
3 Aug 2020
70,531
26 May 2020 Cameron Turtle
Chief Business Officer
Využitie opcie 2,500 $17.00 $42,500
26 May 2020
77,655
1 May 2020 Cameron Turtle
Chief Business Officer
Predaj 10,000 $40.84 $408,400
1 May 2020
75,155
3 Feb 2020 Cameron Turtle
Chief Business Officer
Predaj 12,500 $53.65 $670,625
3 Feb 2020
80,155
6 Dec 2019 Cameron Turtle
Chief Business Officer
Využitie opcie 10,000 $13.20 $132,000
6 Dec 2019
95,155
20 Nov 2019 Cameron Turtle
Chief Business Officer
Predaj 10,000 $55.75 $557,500
20 Nov 2019
85,155
4 Sep 2019 Cameron Turtle
Chief Business Officer
Predaj 5,000 $41.58 $207,900
4 Sep 2019
95,155
4 Jun 2019 Cameron Turtle
Chief Business Officer
Predaj 10,000 $31.64 $316,400
4 Jun 2019
100,155


BridgeBio Pharma Inc executives and stock owners

BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: